Co-targeting of specific epigenetic regulators in combination with CDC7 potently inhibit melanoma growth is a research paper published in iScience (2022). On theSindex it has a DataRank of 0.292. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01CA233481-01A1
National Institutes of Health
Grant: R03CA221926
National Institutes of Health
Grant: R03CA230815
National Institutes of Health
Grant: R03CA248913
National Institutes of Health
Grant: R21CA229927
NCI NIH HHS
Grant: P30 CA013148
NCI NIH HHS
Grant: R01 CA233481
National Institutes of Health
Grant: 5R03CA230815-02
A NOVEL EPIGENETIC IMMUNOTHERAPY FOR OVARIAN CANCER TREATMENT
National Institutes of Health
Grant: 1R21CA229927-01
A DRUGGABLE CHROMATIN MODIFIER PATHWAY IN HCC
National Institutes of Health
Grant: 5R03CA248913-02
A Novel Anoikis Effector that Drives Ovarian Cancer Metastasis
National Institutes of Health
Grant: 7R03CA221926-02
PERSONALIZED THERAPY FOR p16-DEFICIENT MELANOMA
National Institutes of Health
Grant: 5R01CA233481-02
PRECISION METABOLIC THERAPY OF p53 MUTANT TRIPLE NEGATIVE BREAST CANCERS
Fields of Study
Keywords
Sustainable Development Goals